These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29103332)

  • 1. The safety of available treatment options for iron-deficiency anemia.
    Muñoz M; Gómez-Ramírez S; Bhandari S
    Expert Opin Drug Saf; 2018 Feb; 17(2):149-159. PubMed ID: 29103332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the safety of intravenous iron treatments for patients with chronic kidney disease.
    Kassianides X; Hazara AM; Bhandari S
    Expert Opin Drug Saf; 2021 Jan; 20(1):23-35. PubMed ID: 33203251
    [No Abstract]   [Full Text] [Related]  

  • 3. Newer formulations of intravenous iron: a review of their chemistry and key safety aspects - hypersensitivity, hypophosphatemia, and cardiovascular safety.
    Blumenstein I; Shanbhag S; Langguth P; Kalra PA; Zoller H; Lim W
    Expert Opin Drug Saf; 2021 Jul; 20(7):757-769. PubMed ID: 33993818
    [No Abstract]   [Full Text] [Related]  

  • 4. The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review.
    Qunibi WY
    Arzneimittelforschung; 2010; 60(6a):399-412. PubMed ID: 20648931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial.
    Pisani A; Riccio E; Sabbatini M; Andreucci M; Del Rio A; Visciano B
    Nephrol Dial Transplant; 2015 Apr; 30(4):645-52. PubMed ID: 25395392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of intravenous iron administration for uterine bleeding or postpartum anaemia: a narrative review.
    Daniilidis A; Panteleris N; Vlachaki E; Breymann C; Assimakopoulos E
    J Obstet Gynaecol; 2018 May; 38(4):443-447. PubMed ID: 29057687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of intravenous iron supplementation in chronic kidney disease: Interests, limits, and recommendations for a better practice].
    Rottembourg J; Rostoker G
    Nephrol Ther; 2015 Dec; 11(7):531-42. PubMed ID: 26498106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on the evaluation and management of iron deficiency anemia in inflammatory bowel disease.
    Aksan A; Farrag K; Stein J
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):95-97. PubMed ID: 30791779
    [No Abstract]   [Full Text] [Related]  

  • 9. Heme iron polypeptide for the management of anaemia of chronic kidney disease.
    Dull RB; Davis E
    J Clin Pharm Ther; 2015 Aug; 40(4):386-90. PubMed ID: 25953602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease.
    Gisbert JP; Gomollón F
    Am J Gastroenterol; 2008 May; 103(5):1299-307. PubMed ID: 18477354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How we diagnose and treat iron deficiency anemia.
    Auerbach M; Adamson JW
    Am J Hematol; 2016 Jan; 91(1):31-8. PubMed ID: 26408108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice.
    Stein J; Aksan A; Farrag K; Dignass A; Radeke HH
    Expert Opin Pharmacother; 2017 Nov; 18(16):1721-1737. PubMed ID: 29019427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary: Iron deficiency of pregnancy - a new approach involving intravenous iron.
    Auerbach M
    Reprod Health; 2018 Jun; 15(Suppl 1):96. PubMed ID: 29945649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into iron deficiency and iron deficiency anemia.
    Camaschella C
    Blood Rev; 2017 Jul; 31(4):225-233. PubMed ID: 28216263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron therapy for managing anaemia in chronic kidney disease.
    Macdougall IC
    Curr Opin Nephrol Hypertens; 2018 Sep; 27(5):358-363. PubMed ID: 29905580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: a meta-analysis.
    Susantitaphong P; Alqahtani F; Jaber BL
    Am J Nephrol; 2014; 39(2):130-41. PubMed ID: 24513913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease].
    Potthoff SA; Münch HG
    Dtsch Med Wochenschr; 2013 Jun; 138(24):1312-7. PubMed ID: 23737117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron replacement therapy in cancer-related anemia.
    Baribeault D; Auerbach M
    Am J Health Syst Pharm; 2011 May; 68(10 Suppl 1):S4-14; quiz S15-6. PubMed ID: 21543775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous iron therapy in end-stage renal disease.
    Brewster UC
    Semin Dial; 2006; 19(4):285-90. PubMed ID: 16893405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of iron deficiency and anemia after Roux-en-Y gastric bypass surgery: an observational study.
    Malone M; Alger-Mayer S; Lindstrom J; Bailie GR
    Surg Obes Relat Dis; 2013; 9(6):969-74. PubMed ID: 23499191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.